GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) EV-to-EBIT : 2.75 (As of May. 26, 2024)

GlaxoSmithKline Consumer Nigeria EV-to-EBIT Chart

GlaxoSmithKline Consumer Nigeria Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
EV-to-EBIT		Get a 7-Day Free Trial					14.12	4.54	-2.69	-3.99	-8.58

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
EV-to-EBIT	Get a 7-Day Free Trial															-1.77	-2.34	-6.43	-8.58	-14.58

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's EV-to-EBIT

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's EV-to-EBIT falls into.

GlaxoSmithKline Consumer Nigeria EV-to-EBIT Calculation

GlaxoSmithKline Consumer Nigeria's EV-to-EBIT for today is calculated as:

GlaxoSmithKline Consumer Nigeria's current Enterprise Value is ₦2,329 Mil.
GlaxoSmithKline Consumer Nigeria's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₦847 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

GlaxoSmithKline Consumer Nigeria's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

GlaxoSmithKline Consumer Nigeria's Enterprise Value for the quarter that ended in Jun. 2023 was ₦-12,354 Mil.
GlaxoSmithKline Consumer Nigeria's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₦847 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Consumer Nigeria EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description